Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Corporate Governance
2010.05.19
重大投资决策管理制度（2010年5月）
2010.05.19
独立董事关于使用部分超额募集资金归还银行贷款和补充永久性流动资金的议案所发表的独立意见
2010.05.19
董事、监事和高级管理人员所持公司股份及其变动管理制度（2010年5月）
2010.05.19
投资者关系管理制度（2010年5月）
2010.04.16
公司章程（草案）
第一页
上一页
21
22
23
24
25
下一页
最后一页
